Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia

Patrick J. Brassil, Khadija Debri, Hironori Nakura, Shinichi Kobayashi, Donald S. Davies, Robert J. Edwards

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A strain of hyperlipidaemic Sprague-Dawley (HSD) rat was compared with normal Sprague-Dawley (SD) rats for expression of cholesterol 7α-hydroxylase activity (CYP7A1) and other cytochrome P450 (P450) enzymes in liver. Hepatic microsomal CYP7A1 activity in male HSD rats was 2-3-fold lower than in male SD rats with CYP7A1 apoprotein levels being similarly reduced. CYP7A1 expression was subject to diurnal variation in HSD rats as found in SD rats. Treatment of HSD rats with cholestyramine caused an increase in hepatic microsomal cholesterol 7α-hydroxylase activity of 3.3-fold compared with a 3.5-fold increase in SD rats with similar changes in apoprotein levels. These results indicate that the lower activity in HSD rats is not due to a defect in the catalytic activity of the enzyme, regulation affecting diurnal variation or regulation through bile acid feedback inhibition. No difference between hepatic microsomal methoxyresorufin-O-demethylase, benzoxyresorufin-O-debenzylase or chlorzoxazone 6-hydroxylase activities in SD and HSD rats was found, nor was there any difference in the levels of CYP1A2, CYP2D1, CYP2E1, CYP3A1, CYP3A2 or NADPH cytochrome P450 reductase determined by immunoblotting using specific anti-peptide antibodies. However, unlike in male SD rats, CYP2C13 was absent in male HSD rats and this was associated with a two-fold reduction in testosterone 6β-hydroxylase activity. In conclusion, while HSD rats do not have a general reduction in P450 levels, they do lack CYP2C13 and have lowered cholesterol 7α-hydroxylase activity, as a result of a reduced level of expression of the enzyme. Copyright (C) 1998 Elsevier Science, Inc.

Original languageEnglish
Pages (from-to)253-257
Number of pages5
JournalBiochemical Pharmacology
Volume56
Issue number2
DOIs
Publication statusPublished - Jul 15 1998
Externally publishedYes

Fingerprint

Hyperlipidemias
Sprague Dawley Rats
Rats
Liver
Cholesterol 7-alpha-Hydroxylase
Apoproteins
Mixed Function Oxygenases
Cytochrome P-450 Enzyme System
Chlorzoxazone
Cholestyramine Resin
Cytochrome P-450 CYP2E1
Cytochrome P-450 CYP1A2
NADPH-Ferrihemoprotein Reductase
Enzymes
Bile Acids and Salts
Immunoblotting
Testosterone
Anti-Idiotypic Antibodies
Catalyst activity
Feedback

Keywords

  • Cholesterol 7α-hydroxylase
  • Cholestyramine
  • CYP2C13
  • CYP7A1
  • Cytochrome P450
  • Diurnal variation
  • Spontaneously hyperlipidaemic rat

ASJC Scopus subject areas

  • Pharmacology

Cite this

Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia. / Brassil, Patrick J.; Debri, Khadija; Nakura, Hironori; Kobayashi, Shinichi; Davies, Donald S.; Edwards, Robert J.

In: Biochemical Pharmacology, Vol. 56, No. 2, 15.07.1998, p. 253-257.

Research output: Contribution to journalArticle

Brassil, Patrick J. ; Debri, Khadija ; Nakura, Hironori ; Kobayashi, Shinichi ; Davies, Donald S. ; Edwards, Robert J. / Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia. In: Biochemical Pharmacology. 1998 ; Vol. 56, No. 2. pp. 253-257.
@article{eab4ffecf9d4406a96f891f50c6799e4,
title = "Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia",
abstract = "A strain of hyperlipidaemic Sprague-Dawley (HSD) rat was compared with normal Sprague-Dawley (SD) rats for expression of cholesterol 7α-hydroxylase activity (CYP7A1) and other cytochrome P450 (P450) enzymes in liver. Hepatic microsomal CYP7A1 activity in male HSD rats was 2-3-fold lower than in male SD rats with CYP7A1 apoprotein levels being similarly reduced. CYP7A1 expression was subject to diurnal variation in HSD rats as found in SD rats. Treatment of HSD rats with cholestyramine caused an increase in hepatic microsomal cholesterol 7α-hydroxylase activity of 3.3-fold compared with a 3.5-fold increase in SD rats with similar changes in apoprotein levels. These results indicate that the lower activity in HSD rats is not due to a defect in the catalytic activity of the enzyme, regulation affecting diurnal variation or regulation through bile acid feedback inhibition. No difference between hepatic microsomal methoxyresorufin-O-demethylase, benzoxyresorufin-O-debenzylase or chlorzoxazone 6-hydroxylase activities in SD and HSD rats was found, nor was there any difference in the levels of CYP1A2, CYP2D1, CYP2E1, CYP3A1, CYP3A2 or NADPH cytochrome P450 reductase determined by immunoblotting using specific anti-peptide antibodies. However, unlike in male SD rats, CYP2C13 was absent in male HSD rats and this was associated with a two-fold reduction in testosterone 6β-hydroxylase activity. In conclusion, while HSD rats do not have a general reduction in P450 levels, they do lack CYP2C13 and have lowered cholesterol 7α-hydroxylase activity, as a result of a reduced level of expression of the enzyme. Copyright (C) 1998 Elsevier Science, Inc.",
keywords = "Cholesterol 7α-hydroxylase, Cholestyramine, CYP2C13, CYP7A1, Cytochrome P450, Diurnal variation, Spontaneously hyperlipidaemic rat",
author = "Brassil, {Patrick J.} and Khadija Debri and Hironori Nakura and Shinichi Kobayashi and Davies, {Donald S.} and Edwards, {Robert J.}",
year = "1998",
month = "7",
day = "15",
doi = "10.1016/S0006-2952(98)00015-X",
language = "English",
volume = "56",
pages = "253--257",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia

AU - Brassil, Patrick J.

AU - Debri, Khadija

AU - Nakura, Hironori

AU - Kobayashi, Shinichi

AU - Davies, Donald S.

AU - Edwards, Robert J.

PY - 1998/7/15

Y1 - 1998/7/15

N2 - A strain of hyperlipidaemic Sprague-Dawley (HSD) rat was compared with normal Sprague-Dawley (SD) rats for expression of cholesterol 7α-hydroxylase activity (CYP7A1) and other cytochrome P450 (P450) enzymes in liver. Hepatic microsomal CYP7A1 activity in male HSD rats was 2-3-fold lower than in male SD rats with CYP7A1 apoprotein levels being similarly reduced. CYP7A1 expression was subject to diurnal variation in HSD rats as found in SD rats. Treatment of HSD rats with cholestyramine caused an increase in hepatic microsomal cholesterol 7α-hydroxylase activity of 3.3-fold compared with a 3.5-fold increase in SD rats with similar changes in apoprotein levels. These results indicate that the lower activity in HSD rats is not due to a defect in the catalytic activity of the enzyme, regulation affecting diurnal variation or regulation through bile acid feedback inhibition. No difference between hepatic microsomal methoxyresorufin-O-demethylase, benzoxyresorufin-O-debenzylase or chlorzoxazone 6-hydroxylase activities in SD and HSD rats was found, nor was there any difference in the levels of CYP1A2, CYP2D1, CYP2E1, CYP3A1, CYP3A2 or NADPH cytochrome P450 reductase determined by immunoblotting using specific anti-peptide antibodies. However, unlike in male SD rats, CYP2C13 was absent in male HSD rats and this was associated with a two-fold reduction in testosterone 6β-hydroxylase activity. In conclusion, while HSD rats do not have a general reduction in P450 levels, they do lack CYP2C13 and have lowered cholesterol 7α-hydroxylase activity, as a result of a reduced level of expression of the enzyme. Copyright (C) 1998 Elsevier Science, Inc.

AB - A strain of hyperlipidaemic Sprague-Dawley (HSD) rat was compared with normal Sprague-Dawley (SD) rats for expression of cholesterol 7α-hydroxylase activity (CYP7A1) and other cytochrome P450 (P450) enzymes in liver. Hepatic microsomal CYP7A1 activity in male HSD rats was 2-3-fold lower than in male SD rats with CYP7A1 apoprotein levels being similarly reduced. CYP7A1 expression was subject to diurnal variation in HSD rats as found in SD rats. Treatment of HSD rats with cholestyramine caused an increase in hepatic microsomal cholesterol 7α-hydroxylase activity of 3.3-fold compared with a 3.5-fold increase in SD rats with similar changes in apoprotein levels. These results indicate that the lower activity in HSD rats is not due to a defect in the catalytic activity of the enzyme, regulation affecting diurnal variation or regulation through bile acid feedback inhibition. No difference between hepatic microsomal methoxyresorufin-O-demethylase, benzoxyresorufin-O-debenzylase or chlorzoxazone 6-hydroxylase activities in SD and HSD rats was found, nor was there any difference in the levels of CYP1A2, CYP2D1, CYP2E1, CYP3A1, CYP3A2 or NADPH cytochrome P450 reductase determined by immunoblotting using specific anti-peptide antibodies. However, unlike in male SD rats, CYP2C13 was absent in male HSD rats and this was associated with a two-fold reduction in testosterone 6β-hydroxylase activity. In conclusion, while HSD rats do not have a general reduction in P450 levels, they do lack CYP2C13 and have lowered cholesterol 7α-hydroxylase activity, as a result of a reduced level of expression of the enzyme. Copyright (C) 1998 Elsevier Science, Inc.

KW - Cholesterol 7α-hydroxylase

KW - Cholestyramine

KW - CYP2C13

KW - CYP7A1

KW - Cytochrome P450

KW - Diurnal variation

KW - Spontaneously hyperlipidaemic rat

UR - http://www.scopus.com/inward/record.url?scp=0031726261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031726261&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(98)00015-X

DO - 10.1016/S0006-2952(98)00015-X

M3 - Article

VL - 56

SP - 253

EP - 257

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 2

ER -